Loading provider…
Loading provider…
Cardiovascular Disease Physician in Wayne, PA
NPI: 1114922945Primary Practice Location
MAIN LINE HOSPITAL LANKENAU
100 E Lancaster Ave, Wynnewood, PA
Primary Employer
Main Line Healthcare
mainlinehealth.org
HQ Phone
Get MD Peter's Phone Numberphone_androidMobile
Get MD Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 2,849 | 4,528 |
| 2 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 172 | 208 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 168 | 197 |
Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.
Authors: Daniel Singer, Gregg Fonarow, Larry Allen, Eric Peterson, Bernard Gersh, Gerald Naccarelli, Michael Ezekowitz
Journal: Circ Cardiovasc Qual Outcomes
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
Authors: Jack Ansell, Benjamin Steinberg, Paul Chang, Bernard Gersh, Alan Go, Michael Ezekowitz
Publication Date: 2013-07-18
Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
Authors: Daniel Singer, Kenneth Mahaffey, Gregg Fonarow, Jack Ansell, Elaine Hylek, Bernard Gersh, Gerald Naccarelli, Sean Pokorney, Alan Go
Publication Date: 2018-10-30
Lead Sponsor: Bristol-Myers Squibb
Intervention / Treatment: OTHER: Placebo, DRUG: BMS-986165, DRUG: Apremilast
Lead Sponsor: Bristol-Myers Squibb
Intervention / Treatment: OTHER: Placebo, DRUG: BMS-986165, DRUG: Apremilast
Lead Sponsor: Bristol-Myers Squibb
Intervention / Treatment: DRUG: BMS-986165